Medical Affairs Manager, Italy

MEDICAL AFFAIRS

Medical Affairs International TTR and Italy stands for integrity through unbiased, objective and balanced medical-scientific dialogs with the medical community. It plays a strategic role in a matrix of major responsibilities.

Overview

The Medical Affairs Manager (MAM) is a medical-scientific expert that strategically drives and supports the Medical Affairs objectives of Alnylam in the designated therapeutic area(s).

• They will provide support to all functions within the country to ensure achievement of local objectives, in close collaboration with International and Global Medical Affairs.
• They will put the patient at the centre of their work operating with highest ethical and medical-scientific standards in the spirit of continuously advancing the evidence-based medical standard of care.
• The Medical Affairs Manager is expected to build strong cross-functional relationships with colleagues in Medical Affairs, Clinical Research, Regulatory Affairs, Value and Access, R&D, Patient Advocacy, Commercial and other while maintaining full compliance with all relevant company, industry, legal, and regulatory requirements.
  
  

Key Responsibilities

Support the development and implementation of the strategy and tactical plans for new product launches as well as all for marketed products in close collaboration with all internal stakeholders. This relates to:

• Evidence generation
• Evidence dissemination – including HCP education programs
• Key thought leader engagement programs
• Continuously develop the highest medical-scientific expertise within ATTR Neuropathy (PN) and Cardiomyopathy (CM) and be acknowledged externally and internally as an expert in these areas; by developing peer-to-peer scientific relationships with medical experts in particular and with HCPs in general and by providing medical-scientific support to cross-functional disease area teams.
• Identify and cultivate a network of medical-scientific experts in the field of ATTR
• Identify (country specific) evidence gaps and develop the evidence generation plan (including Alnylam sponsored studies, collaborative research agreements and the assessment of investigator initiated studies requests received from medical experts)
• Develop and support the implementation of highest quality medical education activities, including congress symposia, hospital/health care professional educational meetings.
• Provide medical-scientific input concerning the development of advisory boards meetings and support their execution.
• Collaborate with patient advocacy groups.
• Manage requests for Alnylam product supply in off-label and compassionate use cases in accordance with local laws and Alnylam procedures.
• Coordinate the timely and appropriate response to Medical Information inquiries, utilizing global medical information resources and in line with local regulatory requirements.
• Support internal stakeholder in the Market Access process
• Provide training and education for internal team members in relevant therapy areas and product training
  
  

Qualifications

• MD (Medical Doctor) and/or PhD and/or equally academic qualified healthcare professional. Degree in medical/natural science (PhD, MD) is preferred
• Previous experience in the field of cardiology strongly preferred
• Proven basic science and/or clinical background to enable engagement of Health Care Professionals in a scientifically meaningful exchange
• Good analytical skills as applied to medical, scientific and technical information and the ability to cut through scientific complexity
• Experience in clinical research, , and investigator-sponsored trials
• Experience in medical education and KOL engagement programs
• Effective communication skills of evidence based scientific information
• Knowledge of aspects of drug development, GCP and local regulations
• Ability to work collaboratively and cross-functionally
• Management and planning skills as well as decision-making and accountability
• Confident and has the professional competence to win respect and gain credibility at all levels within and outside the company; capable of representing the company externally
• Fluent in Italian and English, both written and verbal
• Willing to travel 50-60% of the time
  
  

About Alnylam: Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality.

Our culture: Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we’ve been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as one of Science Magazine’s Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK – among others.

At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients.